These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33500726)

  • 1. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis.
    Shen W; Zhang X; Tang J; Zhang Z; Du R; Luo D; Liu X; Xia Y; Li Y; Wang S; Yan S; Yang W; Xiang R; Luo N; Luo Y; Li J
    Theranostics; 2021; 11(5):2297-2317. PubMed ID: 33500726
    [No Abstract]   [Full Text] [Related]  

  • 2. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
    Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
    Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3β/β-Catenin Pathway upon LPS Stimulation.
    Li J; Yin J; Shen W; Gao R; Liu Y; Chen Y; Li X; Liu C; Xiang R; Luo N
    Anat Rec (Hoboken); 2017 Jul; 300(7):1219-1229. PubMed ID: 28296189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
    Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
    Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
    Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
    Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICAM3 mediates inflammatory signaling to promote cancer cell stemness.
    Shen W; Xie J; Zhao S; Du R; Luo X; He H; Jiang S; Hao N; Chen C; Guo C; Liu Y; Chen Y; Sun P; Yang S; Luo N; Xiang R; Luo Y
    Cancer Lett; 2018 May; 422():29-43. PubMed ID: 29477378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
    Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
    Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
    [No Abstract]   [Full Text] [Related]  

  • 11. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
    Li M; Mu XD; Song JR; Zhai PT; Cheng Y; Le Y; Li ZB
    Cell Cycle; 2021 May; 20(10):1010-1020. PubMed ID: 33970778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 13. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase 3A Represents a Therapeutic Target that Drives Stem Cell-like Property and Metastasis in Breast Cancer.
    Hao N; Shen W; Du R; Jiang S; Zhu J; Chen Y; Huang C; Shi Y; Xiang R; Luo Y
    Mol Cancer Ther; 2020 Mar; 19(3):868-881. PubMed ID: 31871268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
    Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
    Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
    Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.
    Ke X; Yuan Y; Guo C; Yang Y; Pu Q; Hu X; Tang K; Luo X; Jiang Q; Su X; Liu L; Zhu W; Wei Y
    Oncotarget; 2017 Feb; 8(7):11356-11371. PubMed ID: 28076327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
    Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
    Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer.
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Mol Biol Rep; 2024 May; 51(1):691. PubMed ID: 38796671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
    Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
    Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.